Psychopharmacology

, Volume 94, Issue 2, pp 147–160 | Cite as

Is the forced swimming test a suitable model for revealing antidepressant activity?

  • Franco Borsini
  • Alberto Meli
Review

Abstract

The forced swimming test is reviewed. This test appears to be suitable for detecting antidepressant activity in rats but not in mice. Difference in experimental procedure may account for the different sensitivity to drugs of the two animal species.

Key words

Forced swimming test Depression Validity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abou-Saleh MT, Coppen A (1983) Classification of depression and response to antidepressive therapies. Br J Psychiatry 43:601–603Google Scholar
  2. Akiskal HS, McKinney WT (1973) Depressive disorders: towards an unified hypothesis. Science 182:20–29Google Scholar
  3. Allikmets LH, Lapin IP (1967) Influence of lesions of the amygdaloid complex on behaviour and on effects of antidepressants in rats. Int J Neuropharmacol 6:99–108Google Scholar
  4. Amir S (1982) Involvement of endogenous opioids with forced swimming-induced immobility in mice. Physiol Behav 28:249–251Google Scholar
  5. Araki H, Kawashima K, Aihara H (1984) The difference in the site of actions of tricyclic antidepressants and metamphetamine on the duration of the immobility in the behavioral despair test. Jpn J Pharmacol 35:67–72Google Scholar
  6. Araki H, Kawashima K, Uchiyama Y, Aihara H (1985) Involvement of amygdaloid catecholaminergic mechanism in suppressive effects of desipramine and imipramine duration of immobility in rats forced to swim. Eur J Pharmacol 113:313–318Google Scholar
  7. Arletti R, Baraldi M, Castelli M, Bertolini A (1985) Oxytocin has antidepressant activity. 4th Capo Boi Conference on Neuroscience, June 2–7, Sardinia, ItalyGoogle Scholar
  8. Bartholini G, Lloyd KG, Scatton B, Zivkovic B, Morselli PL (1985) The GABA hypothesis of depression and antidepressant drug action. Psychopharmacol Bull 21:385–387Google Scholar
  9. Berettera C, Invernizzi R, Pulvirenti L, Samanin R (1986) Chronic treatment with iprindole reduces immobility of rats in the behavioural “despair” test by activating dopaminergic mechanisms in the brain. J Pharm Pharmacol 38:313–315Google Scholar
  10. Betin C, DeFeudis FV, Blavet N, Clostre F (1982) Further characterization of the behavioral despair test in mice: positive effects of convulsants. Physiol Behav 28:307–311Google Scholar
  11. Biziere K, Kan JP, Souilhac J, Muyard JP, Roncucci R (1982) Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug. Arzneimittelforschung/Drug Res 32:824–831Google Scholar
  12. Biziere K, Worms P, Kan JP, Mandel P, Garattini S, Roncucci R (1985) Minaprine, a new drug with antidepressant properties. Drugs Exp Clin Res 11:831–840Google Scholar
  13. Borsini F, Bendotti C, Velkov V, Rech R, Samanin R (1981) Immobility test: effects of 5-hydroxytryptaminergic drugs and role of catecholamines in the activity of some antidepressants. J Pharm Pharmacol 33:33–37Google Scholar
  14. Borsini F, Nowakowska E, Samanin R (1984) Effect of repeated treatment with desipramine in the behavioral “despair” test in rats: antagonism by “atypical” but not “classical” neuroleptics or antiadrenergic drugs. Life Sci 34:1171–1176Google Scholar
  15. Borsini F, Nowakowska E, Pulvirenti L, Samanin R (1985a) Repeated treatment with amitriptyline reduces immobility in the behavioral “despair” test by activating dopaminergic and β-adrenergic mechanisms. J Pharm Pharmacol 37:137–138Google Scholar
  16. Borsini F, Pulvirenti L, Samanin R (1985b) Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioural “despair” test in rats. Eur J Pharmacol 110:253–256Google Scholar
  17. Borsini F, Evangelista S, Meli A (1986a) Effect of GABAergic drugs in the behavioral “despair” test in rats. Eur J Pharmacol 121:265–268Google Scholar
  18. Borsini F, Mancinelli A, D'Aranno Y, Evangelista S, Meli A (1986b) Role of GABA in the forced swimming test (FST) in rats. Psychopharmacology 89:S9Google Scholar
  19. Borsini F, Volterra G, Meli A (1986c) Does the behavioral “despair” test measure “despair”? Physiol Behav 38:385–386Google Scholar
  20. Breese GR, Muellen RA, Mailman RB, Frye GD, Vogel RA (1978) An alternative to animal models of central nervous system disorders: study of drug mechanisms and disease symptoms in animals. Prog Neuro-Psychopharmacol 2:313–325Google Scholar
  21. Browne RG (1979) Effect of antidepressants and anticholinergics in a mouse “behavioral despair” test. Eur J Pharmacol 58:331–334Google Scholar
  22. Buckett WR, Luscombe GP (1985) Anomalous “depressant” activity of trazodone and related halogenated phenylpiperazines in a putative model of depression. Br J Pharmacol 86:590PGoogle Scholar
  23. Bulach C, Doaré L, Massari B, Simon P (1984) Effect “antidépresseur” de 3 monoamines endogènes: profiles psychopharmacologiques de la noradrénaline, de l'octopamine et de la phényléthylamine. J Pharmacol 15:1–15Google Scholar
  24. Claustre Y, Rivy JP, Dennis T, Scatton B (1986) Pharmacological studies on stress-induced increase in frontal cortical dopamine metabolism in the rat. J Pharmacol Exp Ther 238:693–700Google Scholar
  25. Clineschmidt BV, Flatker LM, Faison E, Holmes R (1979) An in vivo model for investigating α1- and α2-receptors in the CNS: studies with mianserin. Arch Int Pharmacodyn Ther 242:59–76Google Scholar
  26. Cooper BR, Hester TJ, Maxwell RA (1980) Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther 215:127–134PubMedGoogle Scholar
  27. DeGraaf JS, vanRiezen H, Berendsen HHG, vanDelft AML (1985) A set of behavioural tests predicting antidepressant activity. Drug Dev Res 5:291–301Google Scholar
  28. Devoize JL, Rigal F, Eschalier A, Trolese JF (1982) Naloxone inhibits cloimipramine in mouse forced swimming test. Eur J Pharmacol 78:229–231Google Scholar
  29. Devoize JL, Rigal F, Eschalier A, Trolese JF, Renoux M (1984) Influence of naloxone on antidepressant drug effects in the forced swimming test in mice. Psychopharmacology 84:71–75Google Scholar
  30. Drago F, Continella G, Mason GA, Hernandez DE, Scapagnini U (1985) Phospholipid liposomes potentiate the inhibitory effect of antidepressant drugs on immobility of rats in a despair test (constrained swim). Eur J Pharmacol 115:179–184Google Scholar
  31. Duncan GE, Paul IA, Harden TK, Mueller RA, Stumpf WE, Breese GE (1985) Rapid down regulation of beta adrenergic receptors by combining antidepressant drugs with forced swim: a model of antidepressant-induced neural adaptation. J Pharmacol Exp Ther 234:402–408Google Scholar
  32. Duncan GE, Breese GR, Criswell H, Stumpf WE, Mueller RA, Covey JB (1986) Effects of antidepressant drugs injected into the amygdala on behavioral responses of rats in the forced swim test. J Pharmacol Exp Ther 238:758–762Google Scholar
  33. Eschalier A, Rigal F, Devoize JL, Trolese JF, Grillon C (1983) Morphine pretreatment reduces cloimipramine effect in mouse forced-swimming test. Eur J Pharmacol 91:505–507Google Scholar
  34. Esposito E, Ossowska C, Samanin R (1987) Further evidence that noradrenaline is not involved in the antiimmobility activity of chronic desipramine in the rat. Eur J Pharmacol 136:429–432Google Scholar
  35. Fernandez A, Boix F, Guix T, Tobena A (1986) Effects of GABA-agonists on behavioral despair and activity measures. Neurosci Lett [Suppl] 26:S280Google Scholar
  36. Fernandez-Pardal J, Pezzot MC, Gimeno AL (1985) Antidepressant effect of chronic ethanol in adult rats. IRCS Med Sci 13:822–833Google Scholar
  37. Finnegan KY, Terwilliger MT, Berger PA, Hollister LE, Csernansky JG (1987) A comparison of the neurochemical and behavioral effects of clenbuterol and desipramine. Eur J Pharmacol 134:131–136Google Scholar
  38. Frances H, Simon P (1985) Comparison of imipramine-imipraminium in mice. Neuropharmacology 7:659–663Google Scholar
  39. Galina ZH, Kastin AJ (1985) MIF-1 antagonizes warm-, but not cold-water stress-induced analgesia: dissociation from immobility. Peptides 6:1109–1112Google Scholar
  40. Gorka Z, Janus K (1985) Effects of neuroleptics displaying antidepressant activity on behavior of rats in the forced swimming test. Pharmacol Biochem Behav 23:203–206Google Scholar
  41. Gorka Z, Woitasik E (1980) The effect of antidepressants on the behavioral despair in rats. Pol J Pharmacol Pharm 32:463–468Google Scholar
  42. Gorka Z, Ossokova K, Stach R (1979a) The effect of unilateral amygdala lesion on the imipramine action in behavioural despair in rats. J Pharm Pharmacol 31:647–648Google Scholar
  43. Gorka Z, Wojtasik E, Kwiatek H, May J (1979b) Action of serotoninmimetics in the behavioral despair test in rats. Commun Psychopharmacol 3:133–136Google Scholar
  44. Gorka Z, Earley B, Leonard BE (1985) Effect of bilateral olfactory bulbectomy in the rat, alone or in combination with antidepressants, on the learned immobility model of depression. Neuropsychobiology 13:26–30Google Scholar
  45. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62PubMedGoogle Scholar
  46. Havoundjian, Paul SM, Skolnick P (1986) Acute, stress-induced changes in the benzodiazepine-aminobutyric acid receptor complex are confined to the chloride ionophore. J Pharmacol Exp Ther 237:787–793Google Scholar
  47. Hawkins J, Hichs RA, Phillips N, Moore JD (1978) Swimming rats and human depression. Nature 274:512Google Scholar
  48. Hawkins J, Phillips N, Moore JD, Gilliland MA, Dunbar S, Hicks RA (1980) Emotionality and REMD: a rat swimming model. Physiol Behav 25:167–171Google Scholar
  49. Herman ZS, Plech A, Bien E, Wieloch-Depta L, Jez W (1981) Effect of cholinomimetics, cholinolytics and atypical antidepressants in the behavioral despair test in the rat. Pol J Pharmacol Pharm 33:485–489Google Scholar
  50. Hodgson JA (1984) Swimming immobility of REM sleep deprived rats reared in different environments. Physiol Behav 32:17–23Google Scholar
  51. Ikeda M, Nagatsu T (1985) Effect of short-term swimming stress and diazepam on 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindolacetic acid (5-HIAA) levels in the caudate nucleus: an in vivo voltammetric study. Naunyn-Schmiedeberg's Arch Pharmacol 331:23–26Google Scholar
  52. Jefferys D, Copolv D, Irby D, Fundus J (1983) Behavioural effect of adrenalectomy: reversal by glucocorticolids or [d-ala2, met5] enkephalinamide. Eur J Pharmacol 107:331–335Google Scholar
  53. Jefferys D, Copolov D, Fundus JW (1984) Naloxone inhibits both glucocorticoid and [d-ala2, met5] enkephalinamide reversal of behavioural effect of adrenalectomy. Eur J Pharmacol 103:205–210Google Scholar
  54. Jefferys D, Boublik J, Funder J (1985) A x-selective opioidergic pathway is involved in the reversal of a behavioural effect of adrenalectomy. Eur J Pharmacol 107:331–335Google Scholar
  55. Kastin AJ, Scollan EL, Ehrensing RH, Schally AV, Coy DH (1978) Enkephalin and other peptides reduce passiveness. Pharmacol Biochem Behav 9:515–519Google Scholar
  56. Kastin AJ, Abel DA, Ehrensing RH, Coy DH, Graf MY (1984) Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs. Pharmacol Biochem Behav 21:767–771Google Scholar
  57. Katz RJ (1981) Animal models and human depressive disorders. Neurosci Biobehav Rev 5:231–246Google Scholar
  58. Kawashima K, Araki H, Aihara H (1986) Effect of chronic administration of antidepressants on duration of immobility in rats forced to swimm. Jpn J Pharmacol 40:199–204Google Scholar
  59. Kitada Y, Miyauchi T, Satoh A, Satoh S (1981) Effect of antidepressants in the forced swimming test. Eur J Pharmacol 72:145–152Google Scholar
  60. Kitada Y, Miyauchi T, Kanazawa Y, Nakamichi H, Satoh S (1983) Involvement of α- and β1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test. Neuropharmacology 22:1055–1060Google Scholar
  61. Kitada Y, Miyauchi T, Kosasa T, Satoh S (1986) The significance of β-adrenoceptor down regulation in the desipramine action in the forced swimming test. Naunyn-Schmiedeberg's Arch Pharmacol 333:31–35Google Scholar
  62. Kostowski W (1985) Possible interactionship of the locus coeruleus-hippocampal noradrenergic neurons to depression and mode of action of antidepressant drugs. Pol J Pharmacol Pharm 37:727–743Google Scholar
  63. Kostowski A, Danysz W, Nowakowska E (1984a) Studies on brain noradrenergic neurons in animal model for antidepressive activity. Psychopharmacol Bull 20:320–322Google Scholar
  64. Kostowski W, Danysz W, Plaznik A, Nowakowska E (1984b) Studies on the locus coeruleus system in an animal model for antidepressive activity. Pol J Pharmacol Pharm 36:523–530Google Scholar
  65. Koyuncuoglu H, Eroglu L, Altug T (1982) Effect of l-aspartic acid, l-asparagine and/or l-asparaginase on forced swimming-induced immobility, analgesia and decrease in rectal temperature in rats. Experentia 38:117–118Google Scholar
  66. Kulkarni SK, Mehta AK (1985) Purine nucleoside — mediated immobility in mice: reversal by antidepressants. Psychopharmacology 85:460–463Google Scholar
  67. Kulkarni SK, Parale MP (1986) Despair behaviour: a tool in experimental psychopharmacology. A review. Methods Find Exp Clin Pharmacol 8:741–744Google Scholar
  68. Luttinger D, Freedman M, Hamel L, Ward SJ, Perrone M (1985) The effects of serotonin antagonists in a behavioral despair procedure in mice. Eur J Pharmacol 107:53–58Google Scholar
  69. Maj J (1980) Studies on the action of antidepressant drugs of second generation. Pol J Pharmacol Pharm 32:427–449Google Scholar
  70. Maj J, Rogoz Z, Skuza G (1982) Fluvoxamine, a new antidepressant drug, failed to show antiserotonin activity. Eur J Pharmacol 81:287–292Google Scholar
  71. Maj J, Chojnacka-Wojcik E, Lewandowska A, Tatarczynska E, Wiczynska B (1985) The central action of carbamazepine as a potential antidepressant drug. Pol J Pharmacol Pharm 37:47–56Google Scholar
  72. Mancinelli A, D'Aranno V, Borsini F, Meli A (1987) Lack of relationship between effect of desipramine on forced swimming test and brain levels of desipramine or its demethylated metabolite in rats. Psychopharmacology 92:441–443Google Scholar
  73. Martorana PW, Nitz RE (1979) The new antidepressant pirlindole. Arneimittelforschung/Drug Res 29:946–949Google Scholar
  74. McKinney WT, Bunney WE (1969) Animal model of depression: review of evidence and implications for research. Arch Gen Psychiatry 21:240–248Google Scholar
  75. Miyauchi T, Kitada Y, Satoh S (1981) Effects of acutely and chronically administered antidepressants on the brain regional 3-methoxy-4-hydroxyphenylethyleneglycol sulphate in the forced swimming rat. Life Sci 29:1921–1928Google Scholar
  76. Miyauchi T, Kitada Y, Nakamichi H, Satoh S (1984) β-adrenoceptor mediated inhibition of behavioral action of desipramine and of central noradrenergic activity in forced swimming rats. Life Sci 35:543–551Google Scholar
  77. Mogilnicka E, Czyrak A, Maj J (1987) Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifepidine action. Eur J Pharmacol 138:413–416Google Scholar
  78. Nagatani T, Sugihara T, Kodaira R (1984) The effect of diazepam and agents which change GABAergic functions in immobility in mice. Eur J Pharmacol 97:271–275Google Scholar
  79. Nagatani T, Shibata S, Ueki S, Sugihara T, Kodaira R (1985) The effect of various agents affecting the GABAergic function on immobile behavior in forced swimming test. Jpn J Pharmacol 39:237PGoogle Scholar
  80. Natan LB, Chaillet P, Lecomte JM, Marcais H, Uchida G, Costentin (1984) Involvement of endogenous enkefalins in the mouse “behavioral despair” test. Eur J Pharmacol 97:301–304Google Scholar
  81. Nelson LR, Taylor AN, Lewis JN, Branch BJ, Liebeskind JC (1984) Prenatal exposure to ethanol alters responding in a “behavioral despair” paradigm. Proc West Pharmacol Soc 27:583–586Google Scholar
  82. Nomura S, Shimizu J, Kametani H, Kinjo M, Watanabe M, Nakazawa T (1982a) Swimming mice: in search of an animal model for human depression: In: Langer SZ, Takahashi R, Segawa T, Briley M (eds) New vistas in depression. Pergamon Press, Oxford, pp 203–210Google Scholar
  83. Nomura S, Shimizu J, Kinjo M, Kametani H, Nakazawa T (1982b) A new behavioral test for antidepressant drugs. Eur J Pharmacol 83:171–175Google Scholar
  84. Ogawa N, Mizuno S, Mori A, Nukina I, Ota Z, Yamaoto M (1984) Potential anti-depressive effect of thyrotropin releasing hormone (TRH) and its analogues. Peptides 5:743–746Google Scholar
  85. O'Neill KA, Gertner SB (1986) Effects of centrally administered H2 antagonists in the behavioral despair test. Psychopharmacology 90:190–192Google Scholar
  86. O'Neill KA, Valentino D (1982) Escapabality and generalization: effect on “behavioral despair”. Eur J Pharmacol 78:379–380Google Scholar
  87. Parale MP, Kulkarni SK (1986) Clonidine — induced behavioural despair in mice: reversal by antidepressants. Psychopharmacology 89:171–174Google Scholar
  88. Paykel ES (1986) American and european classifications of affective disorders. Pharmakopsychiatry 19:29–32Google Scholar
  89. Pericic D, Manev H, Levant S, Jernet B, Vujic D, Djordjevic N (1986) Effect of dihydroergosine (DHESN) on the serotonergic system and behaviour: is DHESN a new antidepressant agent? Psychopharmacology 90:112–118Google Scholar
  90. Platt JE, Stone EA (1982) Chronic restrain stress elicits a positive antidepressant response on the forced swimming test. Eur J Pharmacol 82:179–181Google Scholar
  91. Plaznik A, Kostowski W (1985) Modification of behavioral response to intra-hippocampal injections of noradrenaline and adrenoceptor agonist by chronic treatment with desipramine and citaloparm: functional aspects of adaptive receptor changes. Eur J Pharmacol 117:245–252Google Scholar
  92. Plaznik A, Danysz W, Kostowski W (1985a) A stimulatory effect of intraaccumbens injections of noradrenaline on the behavior of rats in the forced swimming test. Psychopharmacology 87:119–123Google Scholar
  93. Plaznik A, Danysz W, Kostowski W (1985b) Mesolimbic noradrenaline but not dopamine is responsible for organization of rats behavior in the forced swim test and anti-immobilizing effect of desipramine. Pol J Pharmacol Pharm 37:347–357Google Scholar
  94. Poncelet M, Hakkou F, Simon P (1984) Psychopharmacological profile of diphenylhydantoin in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 8:373–378Google Scholar
  95. Poncelet M, Brochet D, Charmat R, Simon P (1986a) Antidepressant-like effects of diphenylhydantoin in mice: involvement of α-adrenoceptors. Eur J Pharmacol 120:133–135Google Scholar
  96. Poncelet M, Gaudel G, Danti S, Soubrie P, Simon P (1986b) Acute versus repeated administration of desipramine in rats and mice: relationship between brain concentrations and reduction of immobility in the swimming test. Psychopharmacology 90:139–141Google Scholar
  97. Porsolt RD (1981) Behavioral despair. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: neurochemical, behavioral, and clinical perspectives. Raven Press, New York, pp 121–139Google Scholar
  98. Porsolt RD, Bertin A, Jalfre M (1977a) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336Google Scholar
  99. Porsolt RD, LePichon M, Jalfre M (1977b) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730–732PubMedGoogle Scholar
  100. Porsolt RD, Anton G, Blavet N, Jalfre M (1978a) Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379–391Google Scholar
  101. Porsolt RD, Bertin A, Jalfre M (1978b) “Behavioral despair” in rats and mice: strain differences and the effect of imipramine. Eur J Pharmacol 51:291–294Google Scholar
  102. Porsolt RD, Bertin A, Blavet N, Jalfre M (1979) Immobility induced by forced swimming in rats: effect of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201–210Google Scholar
  103. Przegalinski E, Baran L, Palider W, Siwanowicz J (1979) The central action of pizotifen. Psychopharmacology 62:295–300Google Scholar
  104. Przegalinski E, Bigajska K, Siwanowicz J (1980) Psychopharmacological profile of dexamisole. Pol J Pharmacol Pharm 32:21–29Google Scholar
  105. Pulvirenti L, Samanin R (1986) Antagonism by dopamine, but not noradrenaline receptor blockers of the anti-immobility activity of desipramine after different treatment schedules in the rat. Pharmacol Res Commun 18:73–80Google Scholar
  106. Reny PV, Rips R (1985) Potentation by TRH of the effect of imipramine on the forced-swimming test. Br J Pharmacol 85:463–470Google Scholar
  107. Reny V, Desiles M, Rips R (1984) Potentation of antidepressant effect of imipramine by TRH on the forced-swimming test. 14th C.I.N.P. Congress, June 19–23, Florence, ItalyGoogle Scholar
  108. Roose SP, Glassman AH, Walsch BT, Woodring S (1986) Tricyclic non responders: phenomenology and treatment. Am J Psychiatry 143:345–348Google Scholar
  109. Samanin R, Jori A, Bernasconi S, Morpurgo E, Garattini S (1977) Biochemical and pharmacological studies on amineptine (S 1694) and (+)-amineptine in the rat. J Pharm Pharmacol 29:555–558Google Scholar
  110. Sandman CA, O'Halloran JP (1986) Pro-opiomelanocortin, learning, memory and attention. In: de Wied D, Gispen WH, van Wimerma Greidanus (eds) Neuropeptides and behavior, vol I. Pergamon Press, Oxford, pp 397–420Google Scholar
  111. Satoh H, Mori J, Shimomura K, Ono T, Kikuchi H (1984) Effect of zimelidine, a new antidepressant, on the forced swimming test in rats. Jpn J Pharmacol 35:471–473Google Scholar
  112. Schechter MD, Chance WT (1979) Non-specificity of “behavioral despair” as an animal model of depression. Eur J Pharmacol 60:139–142Google Scholar
  113. Seligman MEP, Beagly G (1975) Learned helplessness in the rat. J Comp Physiol Psychol 88:534–541Google Scholar
  114. Seo M, Kiyono S, Shibagaki M (1986) Swimming immobility time decreased in prenatally X-irradiated microencefalic rats. Neurosciences 12:217–222Google Scholar
  115. Shimazoe T, Shibata S, Iwasaki K, Ueki S (1985) Changes in brain catecholamines of the rat subjected to forced swimming in a tank with a water wheel. Jpn J Pharmacol 32:187PGoogle Scholar
  116. Shimazoe T, Shibata S, Yatsugi S-I, Ueki S (1986) The effect of antidepressants in a forced swimming test evaluated by recording vibration of water tank. Jpn J Pharmacol 40:215PGoogle Scholar
  117. Snyder SH (1984) Cholinergic mechanisms in affective disorders. New Engl J Med 311:254–255Google Scholar
  118. Soubrie P, Boissier JR, Lecrubier Y, Simon P (1976) Diazepam et amnesie. Rev Med 19:1082–1090Google Scholar
  119. Stone EA (1979) Reduction by stress of norepinephrine-stimulated accumulation of cyclic AMP in rat cerebral cortex. J Neurochem 32:1335–1338Google Scholar
  120. Sunal R (1986) Influence of naloxone on H2-receptor blocker drugs effects in the “behavioral despair” test. Pharmacol Biochem Behav 25:511–513Google Scholar
  121. Tamborska E, Malec D, Modzelewski J, Langwinski R (1982) Effect of opioids on central serotonin transmission and despair test. Acta Med Pol 23:49–62Google Scholar
  122. Thornton EW, Evans JAC, Harris C (1986) Attenuated response to nomifensine in rats during a swimm test following lesion of the habenula complex. Psychopharmacology 87:81–85Google Scholar
  123. Trzeciak HI, Janas P, Herman ZS (1986) Effects of chronic oral administration of imipramine in the rat forced swimming test. Pol J Pharmacol Pharm 38:179–183Google Scholar
  124. Vaccheri A, Dall'Olio R, Gaggi R, Gandolfi O, Montanaro N (1984) Antidepressant versus neuroleptic activities of sulpiride isomers on four animal models of depression. Psychopharmacology 83:28–33Google Scholar
  125. VanLuijtelaar ELJM, Coenen AML (1985) Paradoxical sleep deprivation and the immobility response in the rat: effects of desipramine and phentolamine. Sleep 8:49–55Google Scholar
  126. Veldhuis HD, DeKorte CCMM, DeKorte ER (1985) Glucocorticoids facilitate the retention of acquired immobility during forced swimming. Eur J Pharmacol 115:211–217Google Scholar
  127. VonVoigtlander PF, Puech AJ (1983) U-43,465: a triazolobenzodiazepine with pronounced antidepressant-like as well as anxiolytic activities in animals. Arch Int Pharmacodyn Ther 266:60–76Google Scholar
  128. Vrijmoed-DeVries MC, Cools AR (1986) Differential effects of striatal onjections of dopaminergic, cholinergic and GABAergic drugs upon swimming behaviour of rats. Brain Res 364:77–90Google Scholar
  129. Wallach MB, Hedley LR (1979) The effects of antihistamines in a modified behavioral despair test. Commun Psychopharmacol 3:35–39Google Scholar
  130. Weiss JM, Simson PG, Hoffman LJ, Ambrose MJ, Cooper S, Webster A (1986) Infusion of adrenergic receptors agonists and antagonists into the locus coeruleus and ventricular system of the brain. Neuropharmacology 25:367–384Google Scholar
  131. Willner P (1983) Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res Rev 6:211–224Google Scholar
  132. Willner P (1984) The validity of animal models of depression. Psychopharmacology 83:1–16PubMedGoogle Scholar
  133. Zebrowska-Lupina I (1980) Presynaptic α-adrenoceptors and the action of tricyclic antidepressant drugs in behavioural despair in rats. Psychopharmacology 71:169–172Google Scholar
  134. Zebrowska-Lupina I, Kozyrska C (1980) The studies on the role of brain dopamine in the action of antidepressant drugs. Naunyn Schmiedeberg's Arch Pharmacol [Suppl] 313:R20Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • Franco Borsini
    • 1
  • Alberto Meli
    • 1
  1. 1.Research Department‘A. Menarini’ PharmaceuticalsFirenzeItaly

Personalised recommendations